Detalles de la búsqueda
1.
How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL.
Blood
; 141(11): 1251-1264, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36416729
2.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
; 141(6): 609-619, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351239
3.
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Blood
; 139(14): 2173-2185, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871373
4.
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
Pediatr Blood Cancer
; 70(1): e30062, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370087
5.
Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia.
Pediatr Blood Cancer
; 68(7): e28940, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704911
6.
Driving two chimeric antigen receptors (CARs) in a row to reduce antigen escape in B-cell acute lymphocytic leukaemia.
Lancet Oncol
; 24(11): 1163-1164, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863087
7.
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Cancer
; 124(4): 816-825, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29125192
8.
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Int J Cancer
; 138(2): 332-9, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235006
9.
A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Cancer
; 120(9): 1417-25, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24473774
10.
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 30(1): 56-70, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821078
11.
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells.
bioRxiv
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38659938
12.
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
Cancer Med
; 13(7): e6966, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572962
13.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv
; 8(9): 2182-2192, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386999
14.
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
J Clin Oncol
; 42(7): 832-841, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060973
15.
Quality of Web-Based Sickle Cell Disease Resources for Health Care Transition: Website Content Analysis.
JMIR Pediatr Parent
; 6: e48924, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100579
16.
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(10): 598-607, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481241
17.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482927
18.
Rachitic changes, demineralization, and fracture risk in healthy infants and toddlers with vitamin D deficiency.
Radiology
; 262(1): 234-41, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22106354
19.
Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies.
Hematol Oncol Clin North Am
; 36(4): 701-727, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780062
20.
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies.
Clin Cancer Res
; 28(18): 3940-3949, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838646